Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Blocklisting Interim Review

4 Jan 2016 07:00

RNS Number : 6391K
Oxford Biomedica PLC
04 January 2016
 

For Immediate Release

4 January 2016

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

30 June 2015

To:

31 December 2015

Balance of unallotted securities under scheme(s) from previous return:

6,845,803

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

523,287

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

6,322,516

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

30 June 2015

To:

31 December 2015

Balance of unallotted securities under scheme(s) from previous return:

26,850,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

5,110,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

21,740,000

 

 

 

Name of contact:

Tim Watts

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRKMGGMMFZGVZZ
Date   Source Headline
31st Jul 20207:00 amRNSOXB Signs Clinical Supply Agreement with Axovant
20th Jul 20204:23 pmRNSOXB notes interim results from AZ on AZD1222
3rd Jul 202010:45 amRNSDirector Dealings / Market Share Purchase
2nd Jul 20203:39 pmRNSDirector Dealings / Market Share Purchase
2nd Jul 20201:34 pmRNSDirector Dealings / Market Share Transactions
1st Jul 20206:30 pmRNSHoldings in Company
1st Jul 20203:44 pmRNSBlock listing Return
1st Jul 20209:13 amRNSTotal Voting Rights
30th Jun 20203:23 pmRNSGrant of options
25th Jun 20209:44 amRNSHolding(s) in Company
24th Jun 202011:45 amRNSHoldings in Company
24th Jun 20209:54 amRNSDirector Dealings / Share Disposal – Replacement
24th Jun 20207:00 amRNSDirector Dealings / Market Share Purchase
23rd Jun 20204:46 pmRNSResult of Annual General Meeting
23rd Jun 20202:47 pmRNSAdmission of shares and Total Voting Rights.
23rd Jun 20207:00 amRNSAnnual General Meeting
19th Jun 20203:26 pmRNSInformation in Relation to Annual General Meeting
19th Jun 20207:00 amRNSResult of Placing
18th Jun 20205:33 pmRNSProposed Placing of new Ordinary Shares
8th Jun 20204:01 pmRNSUpdate on Sanofi Ophthalmology Programmes
8th Jun 20207:00 amRNSFive Year Collaboration Agreement signed with VMIC
1st Jun 20209:06 amRNSTotal Voting Rights
1st Jun 20207:00 amRNSDr Roch Doliveux appointed Non-Executive Chairman
28th May 202012:16 pmRNSClinical & Commercial Supply Agreement with AZ
27th May 202011:26 amRNSDirector Dealings / Market Share Purchase
22nd May 20205:28 pmRNS2019 Annual report and Accounts & AGM Notification
20th May 20202:34 pmRNSHolding(s) in Company
13th May 20206:02 pmRNSHolding(s) in Company
13th May 20207:00 amRNSOXB receives approval for first two Oxbox suites
11th May 20204:25 pmRNSPDMR Dealings / Market Share sale
6th May 202012:36 pmRNSDirectors Dealings / Market Share Purchases
6th May 20207:00 amRNSPreliminary Results
1st May 20209:05 amRNSTotal Voting Rights
28th Apr 20201:04 pmRNSCompliance with LR 9.2.6ER(1)
24th Apr 202011:48 amRNSDirector/PDMR Shareholding
23rd Apr 20208:38 amRNSHolding(s) in Company
22nd Apr 202012:03 pmRNSKymriah receives FDA RMAT designation in FL
20th Apr 20204:49 pmRNSHolding(s) in Company
16th Apr 20203:17 pmRNSNotice of Results Update
8th Apr 20207:00 amRNSOxford Biomedica joins COVID-19 vaccine Consortium
1st Apr 20209:31 amRNSTotal Voting Rights
25th Mar 20201:06 pmRNSDirector Dealings / Market Share Purchase
20th Mar 20209:56 amRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNSOxford Biomedica Business Update
18th Mar 20207:00 amRNSLicense & Supply Agreement with Juno Therapeutics
2nd Mar 20209:22 amRNSTotal Voting Rights
26th Feb 20205:55 pmRNSDirector Dealings / Market Share Purchase
3rd Feb 20205:04 pmRNSClass 2 Transaction Announcement
3rd Feb 202011:56 amRNSTotal Voting Rights
3rd Feb 202011:55 amRNSDirector Dealings / Market Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.